Main Menu
About
Overview
Amgen History
Mission and Values
Leadership
Awards and Accolades
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
Overview
About Clinical Trails
Amgen Clinical Trails
Clinical Trial Diversity
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
Scientific Community Initiatives
Overview
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Overview
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2019 Responsibility Highlights Report
Corporate Responsibility
Strategy & Governance
Overview
Amgen’s Commitment to Patients
Our Approach to Pricing,
Access and Affordability
Access Approaches, Treatments, and Collaborations
Transformative Treatments, Approaches, and Technology
Shaping the Future of Healthcare
Access to Medicine
U.S. Reimbursement Support Services and Financial Assistance Programs
Access to Medicines Initiatives Outside the U.S.
Access to Investigational Medicines
Amgen Foundation
Overview
About the Amgen Foundation
Amgen Foundation Grants
Programs for Teachers
Programs for Students
About the Amgen Foundation
Commitment to Community
Overview
Staff Engagement Programs
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients
Diversity, Inclusion and Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Overview
Performance
2027 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Supplier Diversity
Supplier Sustainability
Workplace
Safety
Wellness
Reporting and Metrics
Overview
Archived Reports
Summary of Data
CDP
Stakeholder Engagement
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
Amgen Worldwide
Overview
Research and Development Strategy
Overview <i class="fa fa-external-link"></i>
Scientific Advisory Boards
Pipeline <i class="fa fa-external-link"></i>
Amgen Competitive Grants <i class="fa fa-external-link"></i>
Clinical Trials
Scientific Community Initiatives
Manufacturing
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
About
Overview
Amgen History
Mission and Values
Leadership
Awards and Accolades
How We Operate
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support Program
Investigator Sponsored Studies
Scientific Community Initiatives
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2019 Responsibility Highlights Report
Corporate Responsibility Strategy & Governance
Amgen's Commitment to Patients
Our Approach to Pricing, Access and Affordability
Access Approaches, Treatments, and Collaborations
Transformative Treatments, Approaches and Technology
Shaping the Future of Healthcare
Access to Medicine
U.S. Reimbursement Support Services and Financial Assistance Programs
Access to Medicines Initiatives Outside the U.S.
Access to Investigational Medicines
Amgen Foundation
Amgen Inspires
About the Amgen Foundation
Programs for Teachers
Programs for Students
Amgen Foundation Grants
Commitment to Community
Staff Engagement Programs
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients List
Diversity, Inclusion & Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Performance
2027 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Supplier Diversity
Supplier Sustainability
Workplace
Safety
Wellness
Reporting and Metrics
Summary of Data
CDP
Stakeholder Engagement
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
X
Home
>
Stories
>
Science and Innovation
>
Science and Innovation Stories
SCIENCE & INNOVATION
01.25.2021
KRAS
G12C
Inhibition Explained: Featuring Dr. Gregory Friberg, Head of Global Development, Oncology, Greg Friberg, Vice President and Therapeutic Area Head for Global Development Oncology
Read more
All Stories
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
SCIENCE & INNOVATION
01.25.2021
KRAS
G12C
Inhibition Explained: Featuring Dr. Gregory Friberg, Head of Global Development, Oncology, Greg Friberg, Vice President and Therapeutic Area Head for Global Development Oncology
SCIENCE & INNOVATION
01.25.2021
Searching for Hope: Bobbi’s Story
SCIENCE & INNOVATION
01.12.2021
Amgen to Showcase New Data From Its Oncology Pipeline in Lung Cancer at the World Conference on Lung Cancer
SCIENCE & INNOVATION
01.07.2021
Amgen Paper Selected for Best of
Cell
, a Rare Honor for Industry Scientists
SCIENCE & INNOVATION
01.05.2021
5 Things to Watch in the U.S. Biosimilars Landscape in 2021
SCIENCE & INNOVATION
12.21.2020
Polygenic Scores Poised to Play Big Role in Disease Prediction and Prevention
SCIENCE & INNOVATION
12.16.2020
Decoding 5 Recent Regulatory and Development Steps for Sotorasib
SCIENCE & INNOVATION
12.07.2020
Rapidly Advancing Development of Amgen’s Investigational KRAS
G12C
Inhibitor
SCIENCE & INNOVATION
12.04.2020
BiTE
®
Technology 101: Learn the What, How, Who and Why of Amgen’s Innovative BiTE Immuno-Oncology Platform
SCIENCE & INNOVATION
11.03.2020
Why Do Up-and-Coming Scientists Join Amgen's Postdoc Program?
Load more
Loading...
